Nabla

Nabla is a clinical AI platform that listens to patient-clinician conversations and automatically drafts structured clinical notes, letting physicians spend more time with patients and less time typing. Positioned as a "Clinical AI Layer," Nabla combines three core capabilities: Ambient Documentation, which captures the encounter and generates a note in seconds; Dictation, a clinical-grade speech-to-text tool embedded at-cursor in Epic and other EHRs for edits and chart updates; and Coding, which suggests E/M and ICD-10 codes grounded in AMA guidelines and the clinical record. Every note and code suggestion stays in the clinician's hands for final review before it enters the chart.

The platform is built for enterprise healthcare deployment, integrating natively with Epic, athenahealth, Oracle Health, NextGen, and Greenway Health through SMART on FHIR, and its newer Nabla Connect module lets EHR vendors embed Nabla's ambient AI into their own products in days rather than months. Nabla supports more than 35 languages and 50+ medical specialties across in-person and telehealth visits, runs on web, iOS, Android, and Chrome, and offers a public developer API for teams building custom clinical workflows on top of its transcription and note-generation engine. Security and compliance are core to the product, with HIPAA, SOC 2 Type 2, ISO 27001, and GDPR compliance and configurable data retention.

Nabla is used by more than 85,000 clinicians across 130+ health systems and provider groups, including Denver Health, Carle Health, CVS Health, and University of Iowa Health Care, processing over 20 million patient encounters a year. A three-arm randomized trial published in NEJM AI compared Nabla and Microsoft DAX against usual care and found measurable documentation-efficiency gains, and the company reports that roughly 55% of clinicians save at least an hour a day on documentation with a meaningful drop in reported burnout.

Founded in Paris in 2018 by Alexandre LeBrun, Delphine Groll, and Martin Raison, Nabla has raised more than $120 million, including a $70 million Series C in 2025 led by HV Capital. In July 2026 the company appointed healthcare-tech executive Brian Manning as CEO to lead its next growth phase, with co-founder Alexandre LeBrun moving into an Executive Chairman role focused on long-term AI strategy. Nabla has also formed a strategic partnership with Yann LeCun's new venture, Advanced Machine Intelligence, to push further into agentic clinical AI.

Nabla does not publish exact pricing on its official website; the primary calls-to-action are a free trial (via app.nabla.com) and "Talk to our team" for enterprise sales. Third-party sources consistently report a free tier with usage limits, with paid individual/clinician plans starting around $119/month per provider and higher tiers reported near $239/month per provider. Larger health-system deployments — Nabla's core market, spanning 130+ organizations — are sold via custom enterprise contracts with volume-based pricing, with independent estimates placing typical enterprise rates in the $150-$400/month per provider range depending on scale, EHR integration depth, and features. Exact costs require a sales conversation with Nabla.